Wetware World
Partner manufactured Verified against a primary source

Human iPSC Lines

Undifferentiated human induced pluripotent stem cell lines as a starting material for customer-run differentiation.

WW-CL-84697SHEET 1/1
CategoryHuman & iPSC-Derived Cells
UnitOne cryopreserved vial (typically 0.5-1.0 x 10^6 cells)
Lead time2-6 weeks including MTA execution
PricingPublished list price
ProvenancePartner manufactured
Data current2026-09-01

Description

Undifferentiated human iPSC lines supplied as cryopreserved vials, for customers who intend to run their own differentiation or who need a specific genetic background as the foundation of a longer program. This is the deepest point of the supply chain we broker and the one with the heaviest paperwork — most lines carry a material transfer agreement, donor consent terms and use restrictions that constrain commercial use and sometimes sequencing. Public prices exist and cluster tightly: iXCells lists 30HU-002 Human iPS Cell Line (Normal), 0.5-1.0 x 10^6 cells per vial, at $1,634.00, live-verified 2026-09-01, and ATCC lists several hiPSC lines including ACS-1013 (ATCC-DYS0530) at $1,739.00, re-confirmed live on the same date. Availability at ATCC is uneven — a substantial number of listed hiPSC catalog numbers currently show as not available for purchase, which is exactly the kind of thing a buyer discovers only at checkout.

Why this is hard to buy today

The line you want is frequently listed but not actually purchasable, and the MTA and use restrictions that determine whether you can commercialise anything downstream are not visible until after you engage.

Price evidence

iXCells 30HU-002 Human iPS Cell Line (Normal), 0.5-1.0e6 cells/vial: $1,634.00 (live store API, 2026-09-01). ATCC ACS-1013 ATCC-DYS0530 hiPSC: $1,739.00 (live page fetch, 2026-09-01); ACS-1021, ACS-1014 and ACS-1012 also $1,739.00 each.

These are supplier list prices we located and recorded, not a quotation from Wetware World. Your price depends on quantity, specification and freight, and is only binding once issued in writing.

What you must specify

A quote cannot be produced without these. Anything you leave open, a supplier will assume — usually expensively.

#Parameter
01Required genetic background or named mutation
02Isogenic control requirement
03Reprogramming method and footprint constraints, if any
04Karyotype and pluripotency documentation required
05Intended use (research / commercial / therapeutic) for MTA scoping
06Feeder-free vs feeder-dependent culture requirement

Quality documentation

Typically available with this item. What actually ships is confirmed on the quotation, per supplier.

  • Supplier certificate of analysis
  • Pluripotency marker documentation
  • Karyotype report per supplier
  • Sterility and mycoplasma per supplier release testing
  • Donor consent and MTA documentation

Candidate suppliers

Organisations we have identified as capable. Listing does not imply a partnership, an endorsement, or that they have agreed to quote.

OrganisationBasis for inclusion
iXCells Biotechnologies Public WooCommerce Store API returns live USD list prices per SKU; queried directly 2026-09-01.
ATCC Public catalog pricing; ACS-1013 hiPSC page re-fetched live 2026-09-01 showing $1,739.00.

Sources

  1. https://ixcellsbiotech.com
  2. https://www.atcc.org

doc WW-CL-84697 · rev 2026-09-01 · research use only · prices indicative and not binding until quoted in writing